Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Changes in Lactate Production, Lactate Dehydrogenase Genes Expression and DNA Methylation in Response to Tamoxifen Resistance Development in MCF-7 Cell Line

(2021) Lama Hamadneh et al.   Genes

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer

(2021) Esmael Besufikad Belachew et al.   Frontiers in Endocrinology

Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1

(2021) Yan Zhao et al.   Aging-US

PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients

(2021) Lama Hamadneh et al.   Breast Cancer

Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells

(2021) Penn Muluhngwi et al.   Cancers

LNX1 Contributes to Cell Cycle Progression and Cisplatin Resistance

(2021) Minsu Jang et al.   Cancers

Breast Cancer Cell Subtypes Display Different Metabolic Phenotypes That Correlate with Their Clinical Classification

(2021) Consuelo Ripoll et al.   Biology-Basel

Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells

(2020) Seung-Su Kim et al.   BREAST CANCER RESEARCH AND TREATMENT

Knockdown of MMP‑1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c‑myc signaling pathway and EMT

(2020) Kai Wang et al.   ONCOLOGY REPORTS

The NFκB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers

(2020) Irida Kastrati et al.   MOLECULAR CANCER RESEARCH

IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation

(2020) Yan Zheng et al.   Frontiers in Endocrinology

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen

(2020) Anieta M. Sieuwerts et al.   Cancers

TCONS_00012883 promotes proliferation and metastasis via DDX3/YY1/MMP1/PI3K‐AKT axis in colorectal cancer

(2020) Peng Yang et al.   Clinical and Translational Medicine

Overexpression miR‐24‐3p repressed Bim expression to confer tamoxifen resistance in breast cancer

(2019) Xu Han et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

ChIP-seq analysis reveals alteration of H3K4 trimethylation occupancy in cancer-related genes by cold atmospheric plasma

(2018) Seungyeon Lee et al.   FREE RADICAL BIOLOGY AND MEDICINE

MMP‑1 is overexpressed in triple‑negative breast cancer tissues and the knockdown of MMP‑1 expression inhibits tumor cell malignant behaviors in�vitro

(2018) Qi‑Min Wang et al.   Oncology Letters

Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell

(2017) Seungyeon Lee et al.   FREE RADICAL BIOLOGY AND MEDICINE

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer

(2016) Eun-Shin Lee et al.   BMC CANCER

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008

(2015) Rachel J.D. Cossetti et al.   JOURNAL OF CLINICAL ONCOLOGY

Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival

(2015) Mariya Farooqui et al.   Molecular Cancer

DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer

(2015) Andrew Stone et al.   Nature Communications

Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)

(2014) RUBÍ VIEDMA-RODRÍGUEZ et al.   ONCOLOGY REPORTS

Estrogen receptor beta and truncated variants enhance the expression of transfected MMP-1 promoter constructs in response to specific mechanical loading

(2014) John D Thaler et al.   Biology of Sex Differences

Injury-SpecificEx VivoTreatment of the Donor Lung: Pulmonary Thrombolysis Followed by Successful Lung Transplantation

(2013) Tiago N. Machuca et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines

(2013) Kristin E Williams et al.   Epigenetics

Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer

(2011) Sun Jung Kim et al.   CANCER LETTERS

Epigenetic regulation of proMMP-1 expression in the HT1080 human fibrosarcoma cell line

(2011) Aurelie Trussardi-Regnier   INTERNATIONAL JOURNAL OF ONCOLOGY

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma

(2011) Ming Li et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum

(2010) P. E. Lønning   ANNALS OF ONCOLOGY

Matrix Metalloproteinase-1 Expression Can Be Upregulated through Mitogen-Activated Protein Kinase Pathway under the Influence of Human Epidermal Growth Factor Receptor 2 Synergized with Estrogen Receptor

(2010) H. H. Jung et al.   MOLECULAR CANCER RESEARCH

MicroRNA-101-mediated Akt activation and estrogen-independent growth

(2010) M Sachdeva et al.   ONCOGENE

ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers

(2009) Joeli A. Brinkman et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

miR-206 Expression Is Down-regulated in Estrogen Receptor  -Positive Human Breast Cancer

(2008) N. Kondo et al.   CANCER RESEARCH